View:
Download DOC
Download PDF
Download XLS
Download XBRL
moh-20220209
0001179929false00011799292022-02-092022-02-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2022 (February 9, 2022)
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware1-3171913-4204626
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
______________
200 Oceangate, Suite 100,Long Beach,California90802
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (562) 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par Value MOHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.
☐


Item 2.02.    Results of Operations and Financial Condition.
On February 9, 2022, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2021, and the Company’s full year 2022 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not part of this report.
Note: The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.
(d)     Exhibits:
Exhibit No.Description
99.1
104
Cover Page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on February 9, 2022 formatted in iXBRL (Inline Extensible Business Reporting Language).


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MOLINA HEALTHCARE, INC.
Date:
February 9, 2022
By:
/s/ Jeff D. Barlow
Jeff D. Barlow
Chief Legal Officer and Secretary
Document
https://cdn.kscope.io/5f9256a1da085c24b69ed39c5e00679a-molinaa03a01a01a17.jpg
News Release
Investor Contact: Joseph Krocheski, Joseph.Krocheski@molinahealthcare.com, 562-951-8382
Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588
Molina Healthcare Reports Fourth Quarter and Year-End 2021 Financial Results
Introduces Full Year 2022 Earnings Guidance

Long Beach, Calif, February 9, 2022 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported fourth quarter 2021 GAAP earnings per diluted share of $1.74 and adjusted earnings per diluted share of $2.88. The Company also reported full year 2021 GAAP earnings per diluted share of $11.25 and adjusted earnings per diluted share of $13.54. Financial results are summarized below:
Quarter endedYear ended
December 31,
 December 31,
 2021202020212020
(In millions, except per-share results)
Premium Revenue$7,166$4,855$26,855$18,299
Total Revenue$7,409$5,235$27,771$19,423
GAAP:
Net Income$103$34$659$673
EPS – Diluted$1.74$0.56$11.25$11.23
Medical Care Ratio (MCR)88.8%90.8%88.3%86.5%
G&A Ratio7.8%8.6%7.4%7.6%
After-tax Margin1.4%0.6%2.4%3.5%
Adjusted:
Net Income (loss)$170($30)$793$640
EPS – Diluted$2.88($0.51)$13.54$10.67
G&A Ratio7.4%8.6%7.2%7.6%
After-tax Margin2.3%(0.6%)2.9%3.3%
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Full Year Highlights
•As of December 31, 2021, the Company served approximately 5.2 million members, an increase of 1.2 million members or 29% year over year.
•Premium revenue was approximately $26.9 billion for the full year 2021, an increase of 47% year over year.
•GAAP earnings were $11.25 per diluted share.
•Adjusted earnings were $13.54 per diluted share.
•The net effect of COVID decreased net income by approximately $3.50 per diluted share in the full year 2021.
•The Company issued its full year 2022 earnings guidance with premium revenue of approximately $28.5 billion and 26% adjusted EPS growth to no less than $17.00 per diluted share.
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 2
February 9, 2022
“We are very pleased with the quarter and our full year results,” said Joseph Zubretsky, President and CEO. “Our proven momentum enables us to continue building this valuable and exemplary health care franchise. We are proud to serve our members in this challenging time while sustaining profitable growth.”

Texas Acquisition
On January 3, 2022, the Company announced that it closed its acquisition of Cigna Corporation’s Texas Medicaid contracts on January 1, 2022.

Premium Revenue
Premium revenue was approximately $26.9 billion for the full year 2021, an increase of 47% compared to the full year 2020. The higher premium revenue reflects increased organic membership in all lines of business and the impact of acquisitions.

Net Income
Net income for the year ended December 31, 2021, was $11.25 per diluted share, compared to $11.23 per diluted share in the year ended December 31, 2020. Adjusted net income for the year ended December 31, 2021, was $13.54 per diluted share, compared to $10.67 per diluted share in the year ended December 31, 2020. The net effect of COVID decreased full year 2021 GAAP and adjusted EPS by $3.50 per diluted share, compared to $2.30 per diluted share a year earlier.

Medical Care Ratio
The consolidated MCR for the year ended December 31, 2021, was 88.3%, compared to 86.5% for 2020. The net effect of COVID increased the consolidated MCR by approximately 90 basis points and impacted all three lines of business. In the prior year, the net effect of COVID increased the consolidated MCR by approximately 50 basis points.
•The Medicaid MCR increased to 88.7% in 2021 compared to 87.4% in 2020 mainly due to portfolio mix, but remained squarely in line with the Company’s long-term target.
•The Medicare MCR increased to 87.2% in 2021 compared to 86.0% in 2020, driven primarily by the net effect of COVID and also in line with the Company’s long-term target.
•The Marketplace MCR increased to 86.9% in 2021 compared to 78.7% in 2020, primarily due to the higher net effect of COVID and non-COVID utilization by Special Enrollment Period members.

General and Administrative Expense Ratio
The G&A ratio for the full year 2021 was 7.4%, compared to 7.6% for the full year 2020. The adjusted G&A ratio was 7.2% for the full year 2021, compared to 7.6% for the full year 2020 reflecting the benefits of scale produced by the Company’s growth and continued disciplined cost management while making the appropriate investments to fuel growth.

Balance Sheet
Cash and investments at the parent company amounted to $348 million as of December 31, 2021, compared to $644 million as of December 31, 2020. The decrease was due to acquisitions and share repurchases partially offset by dividends received from regulated health plan subsidiaries. In November 2021, the Company closed on its private offering of $750 million principal amount of 3.875% senior notes due May 15, 2032. The Company used the proceeds to redeem the entire $700 million outstanding principal amount of its 5.375% senior notes due 2022.
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 3
February 9, 2022

Cash Flow
Operating cash flow for the year ended December 31, 2021, amounted to $2.1 billion and was higher compared to the year ended December 31, 2020, primarily due to growth in operations and the net impact of timing differences in government receivables and payables.

2022 Guidance
The Company expects its full year 2022 total revenue to be approximately $29.5 billion, an increase of approximately 6% from the full year 2021.
Premium revenue for the full year 2022 is expected to be approximately $28.5 billion, an increase of approximately 6% from the full year 2021.
The Company expects its full year 2022 adjusted earnings per share to be no less than $17.00 per share, or 26% growth over the prior year, with key metrics in line with the Company’s long-term targets.
Guidance reflects:
•Lower net effect of COVID;
•Continued strong performance in Medicare and Medicaid;
•The restoration of mid-single digit pretax margin in our Marketplace business; and
•The impact of regulatory headwinds created by the mid-year resumption of redeterminations and the carveout of pharmacy benefits in our California and Ohio contracts.
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Full Year 2022 Guidance (1)
Premium Revenue$28.5B
Total Revenue$29.5B
GAAP Net Income$919M
Adjusted Net Income (2)
$993M
GAAP EPS – Diluted>$15.73
Adjusted EPS – Diluted (2)
>$17.00
Diluted weighted average shares58.4M
Year End Total Membership4.5M
Medicaid4.1M
Medicare 150K
Marketplace250K
MCR88.0%
GAAP G&A Ratio6.9%
Adjusted G&A Ratio6.8%
Effective Tax Rate25.4%
GAAP After-tax Margin 3.1%
Adjusted After-tax Margin3.4%
______________
(1)All amounts are rounded and approximations.
(2) Reconciliations of non-GAAP financial measures at the end of this release.


Conference Call
Management is hosting a conference call and webcast to discuss Molina Healthcare’s fourth quarter and year-end 2021 results at 8:00 a.m. Eastern Time on Thursday, February 10, 2022. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 4
February 9, 2022
number is 8807414. A telephonic replay of the conference call will be available through Thursday, February 24, 2022, by dialing (877) 344-7529 and entering confirmation number 9770251. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 5.2 million members as of December 31, 2021. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2022 guidance, as well as its plans and expectations regarding future developments. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, which is on file with the SEC, and also in its Quarterly Report on Form 10-Q for the periods ended March 31, 2021, June 30, 2021, and September 30, 2021, which are on file with the SEC. Additional information will also be set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which the Company expects to file on or about February 14, 2022.
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of February 9, 2022, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 5
February 9, 2022
MOLINA HEALTHCARE, INC.
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended
Year Ended
 December 31,December 31,
 2021202020212020
 (In millions, except per-share amounts)
Revenue:
Premium revenue$7,166 $4,855 $26,855 $18,299 
Premium tax revenue 211 172 787 649 
Health insurer fees reimbursed— 65 — 271 
Marketplace risk corridor judgment— 128 — 128 
Investment income 13 11 52 59 
Other revenue19 4 77 17 
Total revenue7,409 5,235 27,771 19,423 
Operating expenses:
Medical care costs6,362 4,408 23,704 15,820 
General and administrative expenses579 450 2,068 1,480 
Premium tax expenses211 172 787 649 
Health insurer fees— 68 — 277 
Depreciation and amortization35 24 131 88 
Other31 22 61 31 
Total operating expenses7,218 5,144 26,751 18,345 
Operating income191 91 1,020 1,078 
Other expenses, net:
Interest expense30 30 120 102 
Other expense, net25 10 25 15 
Total other expenses, net55 40 145 117 
Income before income tax expense
136 51 875 961 
Income tax expense33 17 216 288 
Net income$103 $34 $659 $673 
Net income per share – Diluted$1.74 $0.56 $11.25 $11.23 
Diluted weighted average shares outstanding
58.7 59.4 58.6 59.9 
Operating Statistics:
Medical care ratio88.8 %90.8 %88.3 %86.5 %
G&A ratio7.8 %8.6 %7.4 %7.6 %
Premium tax ratio2.9 %3.4 %2.8 %3.4 %
Effective income tax rate24.2 %33.8 %24.7 %30.0 %
After-tax margin1.4 %0.6 %2.4 %3.5 %

-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 6
February 9, 2022
MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
December 31,
20212020
Unaudited
(Dollars in millions,
except per-share amounts)
ASSETS
Current assets:
Cash and cash equivalents$4,438 $4,154 
Investments3,202 1,875 
Receivables2,177 1,672 
Prepaid expenses and other current assets247 175 
Total current assets10,064 7,876 
Property, equipment, and capitalized software, net396 391 
Goodwill and intangible assets, net1,252 941 
Restricted investments212 136 
Deferred income taxes 106 69 
Other assets179 119 
Total assets$12,209 $9,532 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims and benefits payable$3,363 $2,696 
Amounts due government agencies 2,472 1,253 
Accounts payable, accrued liabilities and other842 641 
Deferred revenue370 375 
Total current liabilities7,047 4,965 
Long-term debt2,173 2,127 
Finance lease liabilities219 225 
Other long-term liabilities140 119 
Total liabilities9,579 7,436 
Stockholders’ equity:
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at December 31, 2021, and 59 million shares at December 31, 2020
— — 
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding
— — 
Additional paid-in capital236 199 
Accumulated other comprehensive (loss) income(5)37 
Retained earnings2,399 1,860 
Total stockholders’ equity2,630 2,096 
Total liabilities and stockholders’ equity$12,209 $9,532 
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 7
February 9, 2022
MOLINA HEALTHCARE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended
December 31,
20212020
(In millions)
Operating activities:
Net income$659 $673 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization131 88 
Deferred income taxes(24)(19)
Share-based compensation
72 57 
Loss on debt repayment25 15 
Other, net
33 12 
Changes in operating assets and liabilities:
Receivables(415)(100)
Prepaid expenses and other current assets(19)(16)
Medical claims and benefits payable471 544 
Amounts due government agencies 1,046 446 
Accounts payable, accrued liabilities and other138 86 
Deferred revenue(5)126 
Income taxes7 (14)
Net cash provided by operating activities
2,119 1,898 
Investing activities:
Purchases of investments(2,713)(670)
Proceeds from sales and maturities of investments
1,329 1,097 
Net cash paid in business combinations(129)(755)
Purchases of property, equipment, and capitalized software
(77)(74)
Other, net (63)2 
Net cash used in investing activities(1,653)(400)
Financing activities:
Proceeds from senior notes offering, net of issuance costs740 1,429 
Repayment of senior notes(723)(338)
Common stock purchases
(128)(606)
Common stock withheld to settle employee tax obligations(53)(8)
Contingent consideration liabilities settled(20)— 
Repayment of term loan facility— (600)
Proceeds from borrowings under term loan facility— 380 
Cash paid for partial termination of warrants
— (30)
Cash paid for partial settlement of conversion option
— (27)
Cash received for partial settlement of call option
— 27 
Repayment of principal amount of convertible senior notes
— (12)
Other, net 1 2 
Net cash (used in) provided by financing activities(183)217 
Net increase in cash, cash equivalents, and restricted cash and cash equivalents283 1,715 
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period
4,223 2,508 
Cash, cash equivalents, and restricted cash and cash equivalents at end of period
$4,506 $4,223 
-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 8
February 9, 2022
MOLINA HEALTHCARE, INC.
UNAUDITED SEGMENT DATA
(Dollars in millions)

December 31,
2021
2020
Ending Membership by Segment:
Medicaid4,329,000 3,599,000 
Medicare142,000 115,000 
Marketplace728,000 318,000 
Total (1)
5,199,000 4,032,000 
(1)Approximately 200,000 members, from the Magellan Complete Care acquisition that closed on December 31, 2020, are not included in the totals as of December 31, 2020.


Three Months Ended September 30,
20212020
Premium RevenueMedical
Margin
MCR (1)
Premium RevenueMedical
Margin
MCR (1)
Medicaid$5,146 $532 89.6 %$3,754 $509 86.4 %
Medicare875 151 82.8 632 91 85.6 
Marketplace779 68 91.3 382 70 81.6 
Consolidated$6,800 $751 88.9 %$4,768 $670 85.9 %
Three Months Ended December 31,
20212020
Premium RevenueMedical
Margin
MCR (1)
Premium RevenueMedical
Margin
MCR (1)
Medicaid $5,441 $635 88.3 %$3,850 $377 90.2 %
Medicare 873 101 88.3 616 18 97.1 
Marketplace852 68 92.1 389 52 86.6 
Consolidated$7,166 $804 88.8 %$4,855 $447 90.8 %
Year Ended December 31,
20212020
Premium RevenueMedical
Margin
MCR (1)
Premium RevenueMedical
Margin
MCR (1)
Medicaid $20,461 $2,322 88.7 %$14,265 $1,804 87.4 %
Medicare 3,361 430 87.2 2,512 351 86.0 
Marketplace3,033 399 86.9 1,522 324 78.7 
Consolidated$26,855 $3,151 88.3 %$18,299 $2,479 86.5 %
(1)The MCR represents medical costs as a percentage of premium revenue.

-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 9
February 9, 2022
MOLINA HEALTHCARE, INC.
CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
Year Ended
December 31,
20212020
Unaudited
Medical claims and benefits payable, beginning balance
$2,696 $1,854 
Components of medical care costs related to:
Current year23,943 15,939 
Prior year(239)(119)
Total medical care costs23,704 15,820 
Payments for medical care costs related to:
Current year21,148 13,871 
Prior year2,080 1,507 
Total paid23,228 15,378 
Acquired balances, net of post-acquisition adjustments197 294 
Change in non-risk and other provider payables(6)106 
Medical claims and benefits payable, ending balance
$3,363 $2,696 
Days in claims payable, fee for service (1)
51 50 
__________________
(1)Claims payable includes primarily claims incurred but not paid, or IBNP. It also includes certain fee-for-service payables reported in medical claims and benefits payable amounting to $150 million and $78 million, as of December 31, 2021, and 2020, respectively.

-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 10
February 9, 2022
MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES
(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.
Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.
Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.
Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.
Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.
Adjusted after-tax margin represents adjusted net income, divided by total revenue.
Three Months Ended December 31,Year Ended December 31,
2021202020212020
AmountPer Diluted ShareAmountPer Diluted ShareAmountPer Diluted ShareAmountPer Diluted Share
Net income
$103 $1.74 $34 $0.56 $659 $11.25 $673 $11.23 
Adjustments:
Acquisition-related expenses (1)
49 0.84 18 0.31 93 1.59 22 0.37 
Amortization of intangible assets
14 0.23 4 0.07 49 0.83 16 0.26 
Loss on debt repayment25 0.43 10 0.18 25 0.43 15 0.26 
Marketplace risk corridor judgment— — (128)(2.15)— — (128)(2.14)
Other (2)
— — 12 0.19 9 0.16 31 0.51 
Subtotal, adjustments
88 1.50 (84)(1.40)176 3.01 (44)(0.74)
Income tax effect
(21)(0.36)20 0.33 (42)(0.72)11 0.18 
Adjustments, net of tax
67 1.14 (64)(1.07)134 2.29 (33)(0.56)
Adjusted net income (loss)
$170 $2.88 $(30)$(0.51)$793 $13.54 $640 $10.67 
__________________
(1)Beginning in the third quarter of 2020, reflects non-recurring costs associated with acquisitions, including various transaction and integration costs.
(2)The year ended December 31, 2021 includes change in premium deficiency reserves, loss on sale of property, and restructuring costs. The year ended December 31, 2020 includes charitable contribution, premium deficiency reserves, and restructuring costs.

-MORE-
Molina Healthcare, Inc. Announces Fourth Quarter and Year-End 2021 Results
Page 11
February 9, 2022
MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)
2022 GUIDANCE


Amount
Per Diluted Share (2)
Net income
$919 $15.73 
Adjustments:
Acquisition-related expenses
33 0.56 
Amortization of intangible assets
64 1.10 
Subtotal, adjustments
97 1.66 
Income tax effect (1)
(23)(0.39)
Adjustments, net of tax
74 1.27 
Adjusted net income per diluted share
$993 $17.00 
__________________
(1)Income tax effect calculated at the statutory tax rate of approximately 23.8%.
(2)Computations assume approximately 58.4 million diluted weighted average shares outstanding.
-END-